Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;42(6):185-95.
doi: 10.5051/jpis.2012.42.6.185. Epub 2012 Dec 31.

Anti-inflammatory effect of (-)-epigallocatechin-3-gallate on Porphyromonas gingivalis lipopolysaccharide-stimulated fibroblasts and stem cells derived from human periodontal ligament

Affiliations

Anti-inflammatory effect of (-)-epigallocatechin-3-gallate on Porphyromonas gingivalis lipopolysaccharide-stimulated fibroblasts and stem cells derived from human periodontal ligament

Im-Hee Jung et al. J Periodontal Implant Sci. 2012 Dec.

Abstract

Purpose: (-)-epigallocatechin-3-gallate (EGCG) has been reported to exert anti-inflammatory and antibacterial effects in periodontitis. However, its exact mechanism of action has yet to be determined. The present in vitro study evaluated the anti-inflammatory effects of EGCG on human periodontal ligament fibroblasts (hPDLFs) and human periodontal ligament stem cells (hPDLSCs) affected by bacterial lipopolysaccharide (LPS) extracted from Porphyromonas gingivalis.

Methods: hPDLFs and hPDLSCs were extracted from healthy young adults and were treated with EGCG and/or P. gingivalis LPS. After 1, 3, 5, and 7 days from treatment, cytotoxic and proliferative effects were evaluated using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and bromodeoxyuridine assay, respectively. And then, the gene expressions of hPDLFs and hPDLSCs were observed for interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, osteoprotegerin (OPG), receptor activator of nuclear factor kappa-B ligand (RANKL), and RANKL/OPG using real-time polymerase chain reaction (PCR) at 0, 6, 24, and 48 hours after treatment. The experiments were performed with the following groups for hPDLFs and hPDLSCs; 1) No treat, 2) EGCG alone, 3) P. gingivalis LPS alone, 4) EGCG+P. gingivalis LPS.

Results: The 20 µM of EGCG and 20 µg/mL of P. gingivalis LPS had the lowest cytotoxic effects, so those concentrations were used for further experiments. The proliferations of hPDLFs and hPDLSCs increased in all groups, though the 'EGCG alone' showed less increase. In real-time PCR, the hPDLFs and hPDLSCs of 'EGCG alone' showed similar gene expressions to those cells of 'no treat'. The gene expressions of 'P. gingivalis LPS alone' in both hPDLFs and hPDLSCs were highly increased at 6 hours for IL-1β, IL-6, TNF-α, RANKL, and RANKL/OPG, except the RANKL/OPG in hPDLSCs. However, those increased gene expressions were down-regulated in 'EGCG+P. gingivalis LPS' by the additional treatment of EGCG.

Conclusions: Our results demonstrate that EGCG could exert an anti-inflammatory effect in hPDLFs and hPDLSCs against a major pathogen of periodontitis, P. gingivalis LPS.

Keywords: Anti-inflammatory agents; Lipopolysaccharide; Periodontal ligament; Periodontitis; Porphyromonas gingivalis.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

Figures

Figure 1
Figure 1
Effects of (-)-epigallocatechin-3-gallate (EGCG) and Porphyromonas gingivalis lipopolysaccharide (LPS) on the viability of human periodontal ligament fibroblasts (hPDLFs) and human periodontal ligament stem cells (hPDLSCs). Most of the hPDLFs (A) and hPDLSCs (B) exhibited comparable cell viability in the EGCG-containing media (0, 0.1, 1, 10, and 20 µM) at days 3 to 7, except in 50 and 100 µM (P<0.1). The proliferation of hPDLFs (C) and hPDLSCs (D) treated with 50 µg/mL P. gingivalis LPS exhibited the most significant down-regulation at day 7, while remained unaffected for hPDLFs and less affected for hPDLSCs in other concentrations (i.e., 0, 0.1, 0.5, 1, 5, 10, and 20 µg/mL) (P<0.05). MTT: 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, OD: optical density. a), b), or c)There is a statistically significant difference; a) vs. b), a) vs. c), and b) vs. c) (P<0.1). d), e), or f)There is a statistically significant difference; d) vs. e), d) vs. f), and e) vs. f) (P<0.1).
Figure 2
Figure 2
Proliferative changes of human periodontal ligament fibroblasts (hPDLFs) and human periodontal ligament stem cells (hPDLSCs) treated with Porphyromonas gingivalis lipopolysaccharide (LPS) and (-)-epigallocatechin-3-gallate (EGCG). In general, hPDLFs (A) and hPDLSCs (B) proliferated continuously during the experimental period, with an exponential increase in cell growth being observed from days 5 to 7. The cellular proliferation was generally higher in hPDLSCs than hPDLFs. However, for both hPDLFs and hPDLSCs, the degree of conjugation with bromodeoxyuridine (BrdU) was significantly lower in EGCG-treated groups than in EGCG-untreated groups. Conjugation with BrdU was not affected by treatment with P. gingivalis LPS (P<0.05). OD: optical density. a), b), or c)There is a statistically significant difference; a) vs. b), a) vs. c), and b) vs. c) (P<0.05).
Figure 3
Figure 3
Effects of Porphyromonas gingivalis lipopolysaccharide (LPS) and/or (-)-epigallocatechin-3-gallate (EGCG) on inflammatory mRNA expressions. EGCG-treated cells (human periodontal ligament fibroblasts [hPDLFs] and human periodontal ligament stem cells [hPDLSCs]) showed similar or lower gene expressions than those cells of 'No treat'. The gene expressions of 'P. gingivalis LPS' alone were highly increased at 6 hours, but those increased gene expressions were down-regulated in 'EGCG+P. ginvialis LPS' group by the additional treatment of EGCG. IL-1β: interleukin 1β, IL-6: interleukin 6, TNF-β: tumor necrosis factor-α.
Figure 4
Figure 4
Effects of Porphyromonas gingivalis lipopolysaccharide (LPS) and (-)-epigallocatechin-3-gallate (EGCG) on osteoclastogenesis-related mRNA expression. (A, B, and C) The gene expression of 'P. gingivalis LPS alone' in human periodontal ligament fibroblasts (hPDLFs) was increased at 6 hours in receptor activator of nuclear factor kappa-B ligand (RANKL) and RANKL/osteoprotegerin (OPG), but it was down-regulated in 'EGCG+P. gingivalis LPS' group. (D, E, and F) The 'P. gingivali LPS alone' of human periodontal ligament stem cells (hPDLSCs) showed much higher gene expressions at 6 hours in both of RANKL and OPG, but those up-regulated gene expressions of RANKL and OPG were not increased in 'EGCG+P. gingivalis LPS' group.

Similar articles

Cited by

References

    1. Yamamoto T, Kita M, Oseko F, Nakamura T, Imanishi J, Kanamura N. Cytokine production in human periodontal ligament cells stimulated with Porphyromonas gingivalis. J Periodontal Res. 2006;41:554–559. - PubMed
    1. Seo BM, Miura M, Gronthos S, Bartold PM, Batouli S, Brahim J, et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet. 2004;364:149–155. - PubMed
    1. Slots J, Bragd L, Wikstrom M, Dahlen G. The occurrence of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius in destructive periodontal disease in adults. J Clin Periodontol. 1986;13:570–577. - PubMed
    1. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodontal Res. 1993;28:500–510. - PubMed
    1. Nair SP, Meghji S, Wilson M, Reddi K, White P, Henderson B. Bacterially induced bone destruction: mechanisms and misconceptions. Infect Immun. 1996;64:2371–2380. - PMC - PubMed